Intrinsic Value of S&P & Nasdaq Contact Us

argenx SE ARGX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • NL • USD

SharesGrow Score
80/100
5/7 Pass
SharesGrow Intrinsic Value
$973.18
+17.5%
Analyst Price Target
$1,026.71
+23.9%

argenx SE (ARGX) reported total assets of $8.68B and total liabilities of $1.36B for quarter ending 2025-12-31, resulting in total equity of $7.32B.

The company held $4.44B in cash and short-term investments. Total debt stood at $83.49M, with net debt of $-3.41B. The Debt-to-Equity (D/E) ratio was 0.01 (conservative).

Current ratio is 5.23, indicating strong short-term liquidity. Interest coverage is 362.6x (strong).

Criteria supported by this page:

  • HEALTH (100/100, Pass) — Debt-to-Equity of 0.01, current ratio of 5.23, interest coverage 362.6x — balance sheet is strong
  • MOAT (71/100) — Total assets $8.68B and equity $7.32B support the company's competitive scale
  • VALUE (52/100) — Debt-to-Equity 0.01 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 80/100 with 5/7 criteria passed.

SharesGrow 7-Criteria Score
80/100
SG Score
View full scorecard →
~
VALUE
52/100
Price-to-Earnings & upside
→ Valuation
FUTURE
88/100
Analyst consensus
→ Forecast
~
PAST
50/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
71/100
Proven by this page
GROWTH
100/100
→ Income
INCOME
100/100
→ Income
argenx SE Balance Sheet History
Metric Q4 FY2025 Q2 FY2025 Q4 FY2024 Q2 FY2024
Total Assets $8.68B$7.18B$6.2B$4.8B
Total Liabilities $1.36B$1.08B$704.24M$534.31M
Total Debt $83.49M$43.15M$39.05M$33.96M
Cash & Investments $4.44B$3.93B$3.38B$3.1B
Total Stockholders Equity $7.32B$6.1B$5.5B$4.26B
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message